Recent technological advances allow genomic sequence to be retrieved from extinct species, providing answers to evolutionary questions that were previously inaccessible. The ability to recover hominid autosomal DNA, in particular, promises to resolve controversies surrounding possible interbreeding between modern and archaic humans and the timing of modern human adaptations.

In these respects, the *FOXP2* gene is notable, both because of its involvement in speech and language and because previous studies indicated that the protein was under recent positive selection in modern humans, with (the only) 2 amino acid substitutions as putative targets ([@bib2]; [@bib11]). Genetic variation from extant humans further suggested that the last beneficial fixation occurred in the past 120 thousand years (Ky) ([@bib2]). Recently, however, [@bib5] reported that 2 Neanderthals also carried the 2 derived amino acid alleles. The authors assumed that modern humans and Neanderthals did not interbreed and so argued that selection must have occurred in the ancestor to the 2 populations, over 300 thousand years ago (Kya) ([@bib6]), and that the previous dating was incorrect.

Any model for selection that arises from ancient DNA findings must account for patterns of variation in both archaic and modern human samples. Yet 2 features of the modern human variation data are actually quite unlikely under the scenario proposed by the authors. First, the sample of modern humans shows an excess of high-frequency--derived alleles (i.e., a low frequency of ancestral alleles) in an intron near the 2 amino acid substitutions (see [fig. 1](#fig1){ref-type="fig"}). This pattern is consistent with the recent fixation of a linked beneficial allele and recombination between selected and neutral loci during the selective sweep ([@bib3]; [@bib7]). But if selection took place in the ancestral population of humans and Neanderthals, the ancestral alleles in the intron would have had to remain at low frequency in humans for over 300 Kya. Moreover, the authors also report that 1 of the intronic sites is polymorphic in the 2 Neanderthals, indicating that the ancestral allele was not lost from the Neanderthal population either. Given that low-frequency variants will tend to be rapidly lost from the population by genetic drift, the persistence of ancestral alleles for close to 300 Kya in both Neanderthal and human lineages is unlikely.
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A second feature of the human data is also puzzling. The authors' scenario predicts that the selective sweep was close to completion 300 Kya, yet the selected haplotype appears to have accumulated few mutations since. To demonstrate this, we estimated the time of the most recent common ancestor (tMRCA) of the selected haplotype (see [fig. 1](#fig1){ref-type="fig"}), using an approach sometimes called phylogenetic dating ([@bib10]; [@bib4]). This method does not make assumptions about demography and selection, but only requires that the mutations in the intron be neutral or nearly neutral. Taking this approach, we obtained a mean tMRCA of 42 Kya (see [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/msn091/DC1) online for details). Although there is considerable uncertainty associated with this estimate, it is surprisingly recent if selection took place over 300 Kya (see [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/msn091/DC1) online). In other words, the selective scenario proposed by the authors cannot account readily for patterns of variation in modern humans. Given that we have no power to detect a beneficial substitution that occurred over 250 Kya (cf. [@bib8]) yet we see a footprint of positive selection at *FOXP2*, the conclusion of a recent selective sweep at *FOXP2* is not surprising.

How then can the data from modern humans and Neanderthals be reconciled? If we assume, as do [@bib5], that one or both of the 2 amino acid substitutions were the targets of positive selection, then the data may reflect gene flow between modern human and Neanderthal populations. Low levels of admixture, which currently cannot be excluded ([@bib9]; [@bib6]), could readily explain how the 2 populations share derived *FOXP2* alleles, even though modern human variation data show the footprint of very recent selection. Moreover, assuming that an allele is globally beneficial, low gene flow levels---potentially just a few viable hybrids---could be sufficient for it to spread to another population ([@bib1]). Thus, loci such as *FOXP2* are precisely the regions of the genome where we might expect to see evidence for allele sharing, given low but nonzero admixture between modern humans and Neanderthals.

Alternatively, the recent episode of positive selection in modern humans may not have involved the amino acid sites, in contrast to what has been assumed in previous studies of *FOXP2*. If so, the nonsynonymous substitutions could have occurred at any point since the common ancestor of humans and chimpanzees, either due to positive selection or to genetic drift. This hypothesis could account for the presence of the derived amino acid alleles in Neanderthals. However, if the high-frequency--derived haplotype found in modern humans is due to recent selection at an (unknown) linked site, its presence in 2 Neanderthals becomes difficult to explain. Although one might invoke a set of selective sweeps at different time points, such a scenario would have to account for all aspects of the data, including the recent tMRCA in modern humans as well as the persistence of the ancestral haplotype in both populations for over 300 Ky.

As in all studies of ancient human DNA, an additional concern in interpreting the data is modern human contamination, which could produce the observed results. In the *FOXP2* study, the authors performed a number of assays to try to ensure that the level of genomic DNA contamination was low (see [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/msn091/DC1) online for discussion). They chose 2 bones for which a mitochondrial DNA (mtDNA) assay revealed low levels of modern human mtDNA contamination in their extracts. They then considered a number of control sites in their 2-stage multiplex PCRs, including 2 Y-linked sites to assess contamination by European males (trivially, these are not informative about female contamination). In addition, they assayed 3 non-Y nuclear sites where a previously obtained Neanderthal sequence carried the ancestral allele (see [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/msn091/DC1) online). Assuming that modern humans were fixed for derived alleles at these 3 sites, they interpreted the recovery of ancestral alleles from Neanderthal samples as evidence against contamination.

We genotyped these sites and found all 3 to be polymorphic in a human sample (see [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/msn091/DC1) online). This finding strongly limits the utility of these sites as controls because the recovery of the ancestral allele no longer establishes that Neanderthal DNA was recovered (see table in [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/msn091/DC1) online). This, in turn, reduces the number of interpretable controls performed by [@bib5]: for example, only their mtDNA assay and a single marker on the X chromosome (that only worked in 1 reliable extract) can now be relied on to rule out modern European, female contamination.

The interpretation of the remaining controls depends strongly on a set of implicit assumptions, notably on the relevance of mtDNA contamination assays for nuclear DNA, and whether the amplification of fragments of Neanderthal DNA is uniform among sites and multiplex reactions. We discuss these assumptions in detail in [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/msn091/DC1) online, where we present a framework within which to analyze the control experiments. For the data reported in [@bib5], we find that, depending on which of the assumptions are met, the controls performed may not be sufficient to rule out contamination. By this, we are not suggesting that Neanderthals do not carry the derived *FOXP2* variants, but simply that additional experiments appear to be needed in order to gain greater confidence in the findings of [@bib5] and hence in any interpretation.
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